Optimal Upstream Management Ischemic Risk Assessment Basis for Assessment: Basis for Assessment: l Pain story l Background ASCVD risk l ECG l Troponin in pertinent time frame l Predictive score Options: Options: l UFH and enoxaparin established l Bivalirudin and fondaparinux: New options that are non-inferior l Antiplatelet therapy increasingly more important as ischemic risk increases Basis for Assessment: Basis for Assessment: l Pain story l Background ASCVD risk l ECG l Troponin in pertinent time frame l Predictive score Options: Options: l UFH and enoxaparin established l Bivalirudin and fondaparinux: New options that are non-inferior l Antiplatelet therapy increasingly more important as ischemic risk increases
{}